Arvada medical device developer files Chapter 7 bankruptcy

cytologicAn Arvada-based medical device development company has filed for Chapter 7 bankruptcy.

CytoLogic said in a July 5 filing that it owes about $1.1 million to creditors. The company listed assets of $10,000.

Chapter 7 bankruptcies are typically a liquidation process with a trustee appointed to oversee a sale of the debtor’s assets.

CytoLogic is led by Larry M. David. The company’s website identifies him as CEO and chairman of the company’s board of directors.

The company lists its main office address as 11803 W. 83rd Lane in Arvada.

CytoLogic was founded in 2003 to further develop an immunotherapy device, dubbed Unleash, invented by Dr. Mark D. Howell at Colorado State University, according to the company’s website, which says the devices “are not currently available.”

Howell is among the company’s largest creditors; the bankruptcy filing says CytoLogic owes him $140,990 for a “judgment.”

CytoLogic Chief Scientific Officer Dr. Bernard Kasten and Chief Financial Officer Patricia Wheeler are also listed among the company’s creditors.

CytoLogic also owes $52,312 to law firm Holland & Hart, according to the filing.

Jeffrey S. Brinen of Denver’s KutnerBrinen is representing CytoLogic in the bankruptcy proceedings. He did not respond to a request for comment.

cytologicAn Arvada-based medical device development company has filed for Chapter 7 bankruptcy.

CytoLogic said in a July 5 filing that it owes about $1.1 million to creditors. The company listed assets of $10,000.

Chapter 7 bankruptcies are typically a liquidation process with a trustee appointed to oversee a sale of the debtor’s assets.

CytoLogic is led by Larry M. David. The company’s website identifies him as CEO and chairman of the company’s board of directors.

The company lists its main office address as 11803 W. 83rd Lane in Arvada.

CytoLogic was founded in 2003 to further develop an immunotherapy device, dubbed Unleash, invented by Dr. Mark D. Howell at Colorado State University, according to the company’s website, which says the devices “are not currently available.”

Howell is among the company’s largest creditors; the bankruptcy filing says CytoLogic owes him $140,990 for a “judgment.”

CytoLogic Chief Scientific Officer Dr. Bernard Kasten and Chief Financial Officer Patricia Wheeler are also listed among the company’s creditors.

CytoLogic also owes $52,312 to law firm Holland & Hart, according to the filing.

Jeffrey S. Brinen of Denver’s KutnerBrinen is representing CytoLogic in the bankruptcy proceedings. He did not respond to a request for comment.

This story is for our paid subscribers only. Please become one of the thousands of BusinessDen members today!

Your subscription has expired. Renew now by choosing a subscription below!

For more informaiton, head over to your profile.

Profile


SUBSCRIBE NOW

 — 

 — 

 — 

TERMS OF SERVICE:

ALL MEMBERSHIPS RENEW AUTOMATICALLY. YOU WILL BE CHARGED FOR A 1 YEAR MEMBERSHIP RENEWAL AT THE RATE IN EFFECT AT THAT TIME UNLESS YOU CANCEL YOUR MEMBERSHIP BY LOGGING IN OR BY CONTACTING [email protected].

ALL CHARGES FOR MONTHLY OR ANNUAL MEMBERSHIPS ARE NONREFUNDABLE.

EACH MEMBERSHIP WILL ONLY FUNCTION ON UP TO 3 MACHINES. ACCOUNTS ABUSING THAT LIMIT WILL BE DISCONTINUED.

FOR ASSISTANCE WITH YOUR MEMBERSHIP PLEASE EMAIL [email protected]




Return to Homepage

POSTED IN Commercial Real Estate

Editor's Picks

Leave a Reply

Your email address will not be published. Required fields are marked *